查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829907

2025年全球血流动力学流量调节设备市场报告

Hemodynamic Flow Alteration Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，血流动力学流量调节设备市场呈现强劲成长势头，市场规模从2024年的8.2亿美元成长至2025年的8.8亿美元，复合年增长率达7.9%。预测期内的成长归因于人口老化、医疗成本上涨、心血管疾病及肥胖、糖尿病和高血压等风险因素的盛行率上升，以及研发投入的增加。

预计未来几年，血流动力学流量改变设备市场规模将强劲成长，到2029年将达到12.1亿美元，复合年增长率为8.1%。预测期内的成长归因于神经血管疾病盛行率的上升、对微创神经外科手术的需求、老年患者群体的不断增长、血栓事件风险的上升以及可支配收入的提高。预测期内的主要趋势包括微创手术、生物相容性材料的进步、可穿戴监测系统、人工智慧和机器学习的整合以及与心臟监测系统的整合。

血流动力学调节器是用于调节循环系统内血流的医疗设备。这类器械常用于血管外科手术和心臟治疗等手术。它们可以影响血流速度、方向、阻力和其他参数，从而改善血液循环或减轻重要器官的压力。

血流动力学调节装置的主要类型包括栓塞保护装置和慢性完全阻塞设备。栓塞保护装置专门设计用于捕捉和清除在血管成形术等手术过程中可能脱落的栓塞物质，从而防止其进入重要器官并造成阻塞。这些装置用于各种应用，包括心血管、神经系统、肾臟和呼吸系统疾病，并被多种终端使用者使用，包括医院、诊所、门诊护理中心和居家照护机构。

2025年春季美国关税大幅上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供血流动力学流量调节设备市场统计数据，例如全球市场规模、各地区份额、竞争对手的市场份额、详细的血流动力学流量调节设备细分市场、市场趋势以及血流动力学流量调节设备行业的商机，为您提供在血流动力学流量调节设备行业取得成功所需的数据。本血流动力学流量调节设备市场研究报告透过对产业现状和未来情势的详细分析，全面概述了您所需的一切。

未来五年预测成长率为8.1%，较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会透过对英国英国和比利时等主要地区的血流改道支架和动脉瘤栓塞线圈征收关税直接影响美国，从而导致神经血管介入治疗的延误和脑动脉瘤治疗费用的增加。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

心血管疾病盛行率的上升预计将推动血流动力学流量调节剂市场的扩张。心血管疾病 (CVD) 包括影响心臟和血管的各种疾病。心血管疾病患者的增加主要是由于人口老化、不健康饮食、久坐不动的生活方式以及高血压和糖尿病等疾病发病率上升等因素造成的。血流动力学流量调节剂对于管理心臟衰竭、高血压和动脉阻塞等心血管疾病患者的血流至关重要。例如，根据英国心血管研究慈善机构英国心臟基金会的报告，英国约有 760 万人患有心臟和循环系统疾病，其中包括 400 万名男性和 360 万名女性。预计到 2030 年这数字将增加 100 万，到 2040 年将再增加 200 万。因此，心血管疾病盛行率的上升是血流动力学流量调节剂市场的主要驱动力。

血流动力学流量改变设备市场的主要企业正致力于开发先进的解决方案，例如左心室辅助装置 (LVAD)，以提供更好的心臟支持、改善患者预后并应对全球日益增长的心臟衰竭发病率。 LVAD 是植入严重心臟衰竭患者体内的机械泵，用于辅助心臟泵血。例如，2022 年 1 月，印度政府下属研究机构印度理工学院坎普尔分校发起了倡议。该计划旨在开发尖端 LVAD，以满足终末期心臟衰竭患者的需求。该设备旨在作为心臟移植的桥樑，或为不适合移植的患者提供长期解决方案。

2024年10月，美国製药公司强生公司（Johnson & Johnson）收购了V-Wave，具体金额未揭露。此次收购旨在透过将V-Wave突破性的文图拉心房分流术纳入其医疗科技产品组合，巩固强生在心血管领域的地位。 V-Wave总部位于美国，专注于开发血流动力学流量调节装置。

血流动力学流量调节设备市场包括流量转向器、血管支架、流量调节器、监测工具和诊断工具的销售。该市场的价值是指“出厂价”，即产品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球血流动力学流量改变设备：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球血流动力学流量调节装置市场：成长率分析
  • 全球血流动力学流量调节设备市场表现：规模与成长，2019-2024
  • 全球血流动力学流量调节设备市场预测：规模与成长，2024-2029年，2034年
  • 全球血流动力学流量调节设备：总目标市场（TAM）

第六章 市场细分

  • 全球血流动力学流量调节设备市场类型、效能及预测（2019-2024、2024-2029、2034）
  • 栓塞保护装置
  • 慢性完全封堵器
  • 全球血流动力学流量调节设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 心血管疾病
  • 神经系统疾病
  • 肾臟疾病
  • 呼吸系统疾病
  • 全球血流动力学流量调节设备市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 门诊治疗中心
  • 居家照护环境
  • 其他最终用户
  • 全球血流动力学流量调节装置市场：按栓塞保护装置细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 远端栓塞保护装置
  • 近端栓塞保护装置
  • 基于过滤器的栓塞防护装置
  • 基于球囊的栓塞保护装置
  • 网状或笼状栓塞防护装置
  • 全球血流动力学流量调节装置市场：慢性完全闭塞装置的细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • CTO交叉导管导引线
  • CTO球囊导管
  • CTO微导管
  • CTO 再入装置
  • CTO支援导管

第七章 区域和国家分析

  • 全球血流动力学流量调节设备市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球血流动力学流量调节设备市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 血流动力学流量调节装置市场：竞争格局
  • 血流动力学流量调节装置市场：公司简介
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Stryker Corporation
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • WL Gore & Associates Inc.
  • ZOLL Medical Corporation
  • Getinge AB
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • Abiomed Inc.
  • LivaNova PLC
  • Cordis US Corp.
  • Silk Road Medical Inc.
  • Berlin Heart GmbH
  • CorWave SA
  • Jarvik Heart Inc.
  • CARMAT SA

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年血流动力学流量调节设备市场：提供新机会的国家
  • 2029 年血流动力学流量调节设备市场：细分市场带来新机会
  • 2029 年血流动力学流量调节设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33761u

Hemodynamic flow alteration devices are medical instruments designed to modify the dynamics of blood flow within the circulatory system. These devices are often utilized in procedures such as vascular surgery or heart condition treatments. They can influence factors such as the speed, direction, or resistance of blood flow to enhance circulation or reduce strain on vital organs.

The primary types of hemodynamic flow alteration devices include embolic protection devices and chronic total occlusion devices. An embolic protection device is specifically designed to capture and remove embolic material that may become dislodged during procedures such as angioplasty. This prevents the material from traveling to vital organs and causing blockages. These devices are used in various applications, including cardiovascular diseases, neurological disorders, renal conditions, and respiratory disorders, and are employed by several end users, including hospitals, clinics, ambulatory care centers, home care settings, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hemodynamic flow alteration devices market research report is one of a series of new reports from The Business Research Company that provides hemodynamic flow alteration devices market statistics, including the hemodynamic flow alteration devices industry global market size, regional shares, competitors with the hemodynamic flow alteration devices market share, detailed hemodynamic flow alteration devices market segments, market trends, and opportunities, and any further data you may need to thrive in the hemodynamic flow alteration devices industry. This hemodynamic flow alteration devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hemodynamic flow alteration devices market size has grown strongly in recent years. It will grow from $0.82 billion in 2024 to $0.88 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to growth in the aging population, rise in healthcare expenditure, increase in the prevalence of cardiovascular diseases, rise in risk factors such as obesity, diabetes, and hypertension, and increase in R&D.

The hemodynamic flow alteration devices market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to the increasing prevalence of neurovascular diseases, demand for minimally invasive neurosurgery, increasing geriatric patients, rising risk of thrombotic events, and rising disposable income. Major trends in the forecast period include minimally invasive procedures, advancements in biocompatible materials, wearable monitoring systems, artificial intelligence and machine learning integration, and integration with cardiac monitoring systems.

The forecast of 8.1% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on flow-diverting stents and aneurysm embolization coils, sourced from key regions such as the UK and Belgium, which could lead to delayed neurovascular interventions and higher costs for treating cerebral aneurysms.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the hemodynamic flow alteration devices market. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels. The rise in CVD cases is primarily attributed to factors such as aging populations, unhealthy diets, sedentary lifestyles, and increasing rates of conditions such as hypertension and diabetes. Hemodynamic flow alteration devices are crucial for managing blood flow in patients with cardiovascular conditions such as heart failure, hypertension, and arterial blockages. For example, a report by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are living with heart and circulatory diseases, with 4 million men and 3.6 million women affected. By 2030, this number is projected to increase by 1 million, and by 2040, it could rise by an additional 2 million. Thus, the growing prevalence of cardiovascular diseases is a key driver for the hemodynamic flow alteration devices market.

Leading companies in the hemodynamic flow alteration devices market are focusing on the development of advanced solutions such as left ventricular assist devices (LVADs) to provide better cardiac support, improve patient outcomes, and tackle the rising incidence of heart failure worldwide. An LVAD is a mechanical pump implanted in patients with severe heart failure to assist the heart in pumping blood. For example, in January 2022, the Indian Institute of Technology-Kanpur, a government research institute based in India, launched an initiative called Hridyantra. This project aims to develop a cutting-edge LVAD to meet the needs of patients with end-stage heart failure. The device is intended to either serve as a bridge to a heart transplant or provide a long-term solution for those who are not candidates for a transplant.

In October 2024, Johnson & Johnson, a pharmaceutical company based in the US, acquired V-Wave Inc. for an undisclosed sum. This acquisition is intended to bolster Johnson & Johnson's position in the cardiovascular disease sector by adding V-Wave's groundbreaking Ventura interatrial shunt to its MedTech portfolio. V-Wave Inc., a US-based company, specializes in the development of hemodynamic flow alteration devices.

Major players in the hemodynamic flow alteration devices market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Getinge AB, Lepu Medical Technology (Beijing) Co. Ltd., Abiomed Inc., LivaNova PLC, Cordis US Corp., Silk Road Medical Inc., Berlin Heart GmbH, CorWave SA, Jarvik Heart Inc., and CARMAT SA.

North America was the largest region in the hemodynamic flow alteration devices market in 2024. The regions covered in hemodynamic flow alteration devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hemodynamic flow alteration devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemodynamic flow alteration devices market consists of sales of flow diverters, vascular stents, blood flow regulators, and monitoring tools. Values in and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemodynamic Flow Alteration Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemodynamic flow alteration devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemodynamic flow alteration devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemodynamic flow alteration devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Embolic Protection Device; Chronic Total Occlusion Device
  • 2) By Application: Cardiovascular Diseases; Neurological Disorders; Renal Disorders; Respiratory Disorders
  • 3) By End User: Hospitals; Clinics; Ambulatory Care Centre; Home Care Setting; Other End Users
  • Subsegments:
  • 1) By Embolic Protection Device: Distal Embolic Protection Devices; Proximal Embolic Protection Devices; Filter-Based Embolic Protection Devices; Balloon-Based Embolic Protection Devices; Mesh Or Cage-Based Embolic Protection Devices
  • 2) By Chronic Total Occlusion Device: Crossing Guidewires For CTO; CTO Balloon Catheters; CTO Microcatheters; Re-Entry Devices For CTO; CTO Support Catheters
  • Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic plc; Siemens Healthcare GmbH; Becton Dickinson and Company; Stryker Corporation; Boston Scientific Corporation; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; ZOLL Medical Corporation; Getinge AB; Lepu Medical Technology (Beijing) Co. Ltd.; Abiomed Inc.; LivaNova PLC; Cordis US Corp.; Silk Road Medical Inc.; Berlin Heart GmbH; CorWave SA; Jarvik Heart Inc.; CARMAT SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemodynamic Flow Alteration Devices Market Characteristics

3. Hemodynamic Flow Alteration Devices Market Trends And Strategies

4. Hemodynamic Flow Alteration Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hemodynamic Flow Alteration Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemodynamic Flow Alteration Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemodynamic Flow Alteration Devices Market Growth Rate Analysis
  • 5.4. Global Hemodynamic Flow Alteration Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemodynamic Flow Alteration Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemodynamic Flow Alteration Devices Total Addressable Market (TAM)

6. Hemodynamic Flow Alteration Devices Market Segmentation

  • 6.1. Global Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolic Protection Device
  • Chronic Total Occlusion Device
  • 6.2. Global Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases
  • Neurological Disorders
  • Renal Disorders
  • Respiratory Disorders
  • 6.3. Global Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Care Centre
  • Home Care Setting
  • Other End Users
  • 6.4. Global Hemodynamic Flow Alteration Devices Market, Sub-Segmentation Of Embolic Protection Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Distal Embolic Protection Devices
  • Proximal Embolic Protection Devices
  • Filter-Based Embolic Protection Devices
  • Balloon-Based Embolic Protection Devices
  • Mesh Or Cage-Based Embolic Protection Devices
  • 6.5. Global Hemodynamic Flow Alteration Devices Market, Sub-Segmentation Of Chronic Total Occlusion Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crossing Guidewires For CTO
  • CTO Balloon Catheters
  • CTO Microcatheters
  • Re-Entry Devices For CTO
  • CTO Support Catheters

7. Hemodynamic Flow Alteration Devices Market Regional And Country Analysis

  • 7.1. Global Hemodynamic Flow Alteration Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemodynamic Flow Alteration Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemodynamic Flow Alteration Devices Market

  • 8.1. Asia-Pacific Hemodynamic Flow Alteration Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemodynamic Flow Alteration Devices Market

  • 9.1. China Hemodynamic Flow Alteration Devices Market Overview
  • 9.2. China Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemodynamic Flow Alteration Devices Market

  • 10.1. India Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemodynamic Flow Alteration Devices Market

  • 11.1. Japan Hemodynamic Flow Alteration Devices Market Overview
  • 11.2. Japan Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemodynamic Flow Alteration Devices Market

  • 12.1. Australia Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemodynamic Flow Alteration Devices Market

  • 13.1. Indonesia Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemodynamic Flow Alteration Devices Market

  • 14.1. South Korea Hemodynamic Flow Alteration Devices Market Overview
  • 14.2. South Korea Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemodynamic Flow Alteration Devices Market

  • 15.1. Western Europe Hemodynamic Flow Alteration Devices Market Overview
  • 15.2. Western Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemodynamic Flow Alteration Devices Market

  • 16.1. UK Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemodynamic Flow Alteration Devices Market

  • 17.1. Germany Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemodynamic Flow Alteration Devices Market

  • 18.1. France Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemodynamic Flow Alteration Devices Market

  • 19.1. Italy Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemodynamic Flow Alteration Devices Market

  • 20.1. Spain Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemodynamic Flow Alteration Devices Market

  • 21.1. Eastern Europe Hemodynamic Flow Alteration Devices Market Overview
  • 21.2. Eastern Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemodynamic Flow Alteration Devices Market

  • 22.1. Russia Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemodynamic Flow Alteration Devices Market

  • 23.1. North America Hemodynamic Flow Alteration Devices Market Overview
  • 23.2. North America Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemodynamic Flow Alteration Devices Market

  • 24.1. USA Hemodynamic Flow Alteration Devices Market Overview
  • 24.2. USA Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemodynamic Flow Alteration Devices Market

  • 25.1. Canada Hemodynamic Flow Alteration Devices Market Overview
  • 25.2. Canada Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemodynamic Flow Alteration Devices Market

  • 26.1. South America Hemodynamic Flow Alteration Devices Market Overview
  • 26.2. South America Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemodynamic Flow Alteration Devices Market

  • 27.1. Brazil Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemodynamic Flow Alteration Devices Market

  • 28.1. Middle East Hemodynamic Flow Alteration Devices Market Overview
  • 28.2. Middle East Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemodynamic Flow Alteration Devices Market

  • 29.1. Africa Hemodynamic Flow Alteration Devices Market Overview
  • 29.2. Africa Hemodynamic Flow Alteration Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemodynamic Flow Alteration Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemodynamic Flow Alteration Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemodynamic Flow Alteration Devices Market Competitive Landscape And Company Profiles

  • 30.1. Hemodynamic Flow Alteration Devices Market Competitive Landscape
  • 30.2. Hemodynamic Flow Alteration Devices Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Hemodynamic Flow Alteration Devices Market Other Major And Innovative Companies

  • 31.1. Stryker Corporation
  • 31.2. Boston Scientific Corporation
  • 31.3. Edwards Lifesciences Corporation
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. ZOLL Medical Corporation
  • 31.6. Getinge AB
  • 31.7. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.8. Abiomed Inc.
  • 31.9. LivaNova PLC
  • 31.10. Cordis US Corp.
  • 31.11. Silk Road Medical Inc.
  • 31.12. Berlin Heart GmbH
  • 31.13. CorWave SA
  • 31.14. Jarvik Heart Inc.
  • 31.15. CARMAT SA

32. Global Hemodynamic Flow Alteration Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemodynamic Flow Alteration Devices Market

34. Recent Developments In The Hemodynamic Flow Alteration Devices Market

35. Hemodynamic Flow Alteration Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Hemodynamic Flow Alteration Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemodynamic Flow Alteration Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemodynamic Flow Alteration Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer